Partnerships for the Development of Novel Assays to Predict Vaccine Efficacy (R01)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement is to solicit applications for projects focused on development, or improvement, of preclinical assays to predict human efficacy for specific investigational vaccines.


  • Letter of Intent Due Date(s): August 30, 2015 
  • Application Due Date(s): September 30, 2015, by 5:00 PM local time of applicant organization.

RFA-AI-15-033 Expiration Date October 1, 2015

Agency Website

Amount Description

Budgets for direct costs of up to $750,000 per year may be requested. Applicants may also request up to an additional $300,000, in year one for major equipment to ensure that research objectives can be met and biohazards can be contained, totaling $1,050,000 direct costs. Consortium F&A is not included in the direct cost limitation.

The scope of the proposed project should determine the project period. The maximum project period is 5 years.

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

September 30, 2015